RTAC:NASDAQRenatus Tactical Acquisition Corp I Analysis
Data as of 2026-04-29 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Renatus Tactical Acquisition Corp I trades at $10.35, just above its short‑term support of $10.27 and below the $10.38 resistance. Technicals show a bearish price trend (20‑day SMA 10.30 < 50‑day SMA 10.36) but a bullish MACD crossover (histogram +0.013) and a neutral RSI (54.5). Volume is slipping, indicating waning market interest. Fundamentally the stock is markedly overvalued – a trailing P/E of 45 versus an industry average of 17.5 and a price‑to‑book of –32.2, with zero revenue and negative book value. The beta of 0.48 suggests modest market sensitivity, while 30‑day volatility sits at just over 3%, yet the max drawdown of –17.8% underscores downside risk. The Fear & Greed Index at “Extreme Greed” reflects strong speculative demand despite weak fundamentals.
Market Outlook
Short Term
< 1 yearKey Factors
- Price hovering near technical support/resistance
- Decreasing volume and bearish SMA alignment
- Overvaluation relative to earnings and book value
Medium Term
1–3 yearsKey Factors
- No operating revenue or cash generation
- High P/E and negative book value persist
- Continued liquidity pressure from falling volume
Long Term
> 3 yearsKey Factors
- Potential upside if a merger or business combination materializes
- Low beta may limit market‑wide volatility exposure
- Current market sentiment (Extreme Greed) could drive speculative price lifts
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.